2024 · pending · WO2025222056A1

Treatment of CDHR3 Related Diseases and Disorders

Gregory McInnes

Compositions comprising oligonucleotides (siRNA or ASO) that target CDHR3 for treating conditions associated with CDHR3 variants.

RNA Therapeutics